Literature DB >> 20582389

[Patient care in the acute phase of stress induced cardiomyopathy (Tako-Tsubo cardiomyopathy)--and thereafter?].

V Kurowski1, P W Radke, H Schunkert, C Burgdorf.   

Abstract

The prognosis of patients presenting with Tako-Tsubo cardiomyopathy (TTC) is generally considered to be favorable. However, in the acute phase of the disorder complications are not infrequent and, therefore, continuous monitoring and consistent therapy in an intensive care unit is essential. Typical complications in patients with TTC are cardiogenic shock, obstruction of the left ventricular outflow tract (LVOT), occasionally accompanied by acute mitral regurgitation, arrhythmias, predominantly torsade de pointes tachycardias due to QT prolongation, left ventricular (LV) thrombus formation with or without consecutive thromboembolic events, and LV rupture. After confirmation of TTC by coronary angiography, repeat echocardiography should be performed. A standardized therapy for patients with TTC has so far not been established. Recommendations for the acute phase include the administration of anxiolytic agents for patients who present with preceding emotional stress, consistent therapy of physical stressors (such as pain or asthma) and avoidance of catecholamine therapy. Shock due to LVOT obstruction is treated by administration of volume and β-blockers. With respect to the occurrence of torsade de pointes tachycardias, drugs which might cause QT prolongation should not be given. The notable incidence of LV thrombus formation justifies therapeutic anticoagulation. Systematic studies and treatment recommendations for the prophylaxis of recurrent TTC do not exist. The recently reported association between TTC and malignant disorders should prompt tumor screening and subsequent preventive medical checkups in patients affected by TTC.

Entities:  

Mesh:

Year:  2010        PMID: 20582389     DOI: 10.1007/s00059-010-3349-8

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  60 in total

1.  Apical ballooning syndrome: an important differential diagnosis of acute myocardial infarction.

Authors:  Abhiram Prasad
Journal:  Circulation       Date:  2007-02-06       Impact factor: 29.690

2.  Tako-tsubo cardiomyopathy mimicking acute aortic dissection: a case report.

Authors:  Hendrik B Sager; Heribert Schunkert; Volkhard Kurowski
Journal:  Int J Cardiol       Date:  2009-01-30       Impact factor: 4.164

3.  [Tako-tsubo cardiomyopathy. Incidence in patients with acute coronary syndrome].

Authors:  Horst Wedekind; Karsten Möller; Karl Heinrich Scholz
Journal:  Herz       Date:  2006-06       Impact factor: 1.443

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Authors:  Scott W Sharkey; Denise C Windenburg; John R Lesser; Martin S Maron; Robert G Hauser; Jennifer N Lesser; Tammy S Haas; James S Hodges; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

6.  Acute and reversible cardiomyopathy provoked by stress in women from the United States.

Authors:  Scott W Sharkey; John R Lesser; Andrey G Zenovich; Martin S Maron; Jana Lindberg; Terrence F Longe; Barry J Maron
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

7.  Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies.

Authors:  Christof Burgdorf; Volkhard Kurowski; Hendrik Bonnemeier; Heribert Schunkert; Peter Walter Radke
Journal:  Eur J Heart Fail       Date:  2008-08-08       Impact factor: 15.534

8.  Cardiogenic shock secondary to Tako-tsubo syndrome after debridement of malignant endobronchial obstruction.

Authors:  Jorge Guerrero; Adnan Majid; Armin Ernst
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

9.  Severe mitral regurgitation in Tako-Tsubo cardiomyopathy.

Authors:  Holger M Nef; Helge Möllmann; Pirmin Hilpert; Franz Masseli; Christian Troidl; Andreas Rolf; Thorsten Dill; Woitek Skwara; Michael Weber; Christian Hamm; A Elsässer
Journal:  Int J Cardiol       Date:  2007-11-28       Impact factor: 4.164

10.  Apical ballooning syndrome complicated by acute severe mitral regurgitation with left ventricular outflow obstruction--case report.

Authors:  Manju D Chandrasegaram; David S Celermajer; Michael K Wilson
Journal:  J Cardiothorac Surg       Date:  2007-02-21       Impact factor: 1.637

View more
  5 in total

1.  [Tako-Tsubo cardiomyopathy--what do, what don't we know?].

Authors:  C Burgdorf; R Erbel
Journal:  Herz       Date:  2010-06       Impact factor: 1.443

Review 2.  Tako-Tsubo syndrome: dying of a broken heart?

Authors:  Ch Sinning; T Keller; N Abegunewardene; K-F Kreitner; T Münzel; S Blankenberg
Journal:  Clin Res Cardiol       Date:  2010-09-17       Impact factor: 5.460

Review 3.  Assessing the Role of High-Dose β-Agonists Use in Triggering Takotsubo Syndrome During Asthma Exacerbation.

Authors:  Danish Abbasi; Saif Faiek; Waqas J Siddiqui; Angel Lopez-Candales
Journal:  Perm J       Date:  2022-04-05

Review 4.  Novel aspects and new roles for the serine protease plasmin.

Authors:  T Syrovets; Th Simmet
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

5.  Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome.

Authors:  Albert Topf; Moritz Mirna; Christiane Dienhart; Peter Jirak; Nina Bacher; Elke Boxhammer; Sarah X Gharibeh; Lukas J Motloch; Uta C Hoppe; Michael Lichtenauer
Journal:  Biomedicines       Date:  2022-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.